Through the contract the Company will supply Two key GMP intermediates for one of the ‘patented drugs' of the Innovator Pharmaceutical customer. Both these products involve 7 steps specialised chemistry. Commercial supplies of both these products will start from FY'23 onwards. The Company will use GMP facility to service this contract.
